NEW RAY MEDIC (06108) Announces Monthly Return as of 31 October 2025

Bulletin Express11-03

New Ray Medicine International Holding Limited, incorporated in Bermuda with limited liability, announced its Monthly Return for Equity Issuer for the period ended 31 October 2025. The total authorized share capital remained at 15,000,000,000 ordinary shares, each with a par value of HKD 0.01, amounting to HKD 150,000,000 in total.

The number of issued ordinary shares stayed at 167,184,665, with no treasury shares recorded. There were 12,820,000 outstanding share options under the company’s share option scheme, and no new shares were issued or treasury shares transferred pursuant to these options during the reporting month. No other warrants, convertibles, or related arrangements were disclosed for the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment